BackRoyalty Pharma plc Overview
Royalty Pharma plc - Ordinary Shares - Class A

Royalty Pharma plc Target Price

Where could RPRX trade next? Consensus target price: $66.

Get informed when a big investor buys or sells

+ Follow

Share Price

$58.61

Average Target Price

$65.5011.8% upside

2 analysts in the last 4 months

High: $66 | Low: $65

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-08-06Goldman Sachs$6612.6% upsideOpen
2026-08-06Morgan Stanley$6510.9% upsideOpen
2026-04-21UBSAshwani Verma$572.7% downsideOpen
2026-04-10Morgan StanleyTerence Flynn$637.5% upsideOpen
2026-02-27Seaport Global$5014.7% downsideOpen
2026-02-12Morgan StanleyTerence Flynn$614.1% upsideOpen
2026-01-30UBSAshwani Verma$4916.4% downsideOpen
2025-12-11Leerink Partners$4523.2% downsideOpen
2025-09-30Goldman Sachs$4228.3% downsideOpen
2025-07-10Morgan StanleyTerence Flynn$547.9% downsideOpen
2024-09-04Goldman SachsChris Shibutani$5113% downsideOpen
2024-07-11Morgan StanleyTerence Flynn$5113% downsideOpen
2024-06-07Goldman SachsChris Shibutani$5014.7% downsideOpen
2024-06-03UBSAshwani Verma$2852.2% downsideOpen
2022-12-06Morgan Stanley$5113% downsideOpen
2022-06-13UBSAshwani Verma$4719.8% downsideOpen

Royalty Pharma plc (RPRX) FAQ

The latest target price for RPRX is $66. Investors often review this figure alongside Royalty Pharma plc's historical trend and sector peers before judging valuation or financial health.

Royalty Pharma plc trades near $58.61 while the consensus target sits at $66 (11.8% upside). Targets are estimates based on earnings forecasts and valuation models; they change when analysts update ratings or revise models. Compare the average with the high and low targets for a fuller picture.

After noting RPRX's target price ($66), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Royalty Pharma plc's target price against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.